| 1 |
Shimozaki K, Shinozaki E, Yamamoto N, Imamura Y, Osumi H, Nakayama I, Wakatsuki T, Ooki A, Takahari D, Ogura M, Chin K, Watanabe M, Yamaguchi K. KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer. J Cancer Res Clin Oncol 2023;149:1273-83. [PMID: 35438321 DOI: 10.1007/s00432-022-03966-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
de Oliveira VA, Monteiro Fernandes ANR, Dos Santos Leal LM, Ferreira Lima PA, Silva Pereira AR, Pereira IC, Negreiros HA, Pereira-Freire JA, da Silva FCC, de Carvalho Melo Cavalcante AA, Torres-Leal FL, Azevedo AP, de Castro E Sousa JM. α-tocopherol as a selective modulator of toxicogenic damage induced by antineoplastic agents cyclophosphamide and doxorubicin. J Toxicol Environ Health A 2023;86:87-102. [PMID: 36756732 DOI: 10.1080/15287394.2023.2168224] [Reference Citation Analysis]
|
| 3 |
Kim YI, Pecha RL, Keihanian T, Mercado M, Pena-Munoz SV, Lang K, Van Buren G, Dhingra S, Othman MO. MUC1 Expressions and Its Prognostic Values in US Gastric Cancer Patients. Cancers (Basel) 2023;15. [PMID: 36831343 DOI: 10.3390/cancers15040998] [Reference Citation Analysis]
|
| 4 |
Wei Q, Zhang Q, Wu Y, Han S, Yin L, Zhang J, Gao Y, Shen H, Zhuang J, Chu J, Liu J, Wei Y. Analysis of bacterial diversity and community structure in gastric juice of patients with advanced gastric cancer. Discov Oncol 2023;14:7. [PMID: 36662326 DOI: 10.1007/s12672-023-00612-7] [Reference Citation Analysis]
|
| 5 |
Kanda M, Terashima M, Kinoshita T, Yabusaki H, Tokunaga M, Kodera Y. A multi-institutional study to evaluate the feasibility of next-generation sequencing and genomic analysis using formalin-fixed, paraffin-embedded biopsies of gastric cancer. Gastric Cancer 2023;26:108-15. [PMID: 36369312 DOI: 10.1007/s10120-022-01351-4] [Reference Citation Analysis]
|
| 6 |
Zhou JY, Liu JY, Tao Y, Chen C, Liu SL. LINC01526 Promotes Proliferation and Metastasis of Gastric Cancer by Interacting with TARBP2 to Induce GNG7 mRNA Decay. Cancers (Basel) 2022;14:4940. [PMID: 36230863 DOI: 10.3390/cancers14194940] [Reference Citation Analysis]
|
| 7 |
Feng Q, Sun B, Xue T, Li R, Lin C, Gao Y, Sun L, Zhuo Y, Wang D. Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers. Front Immunol 2022;13:1025608. [PMID: 36341440 DOI: 10.3389/fimmu.2022.1025608] [Reference Citation Analysis]
|
| 8 |
Li Y, Luo Y, Tian Q, Lai Y, Xu L, Yun H, Liang Y, Liao D, Gu R, Liu L, Yuan M, Li Y, Li Y, Lu M, Yong X, Zhang H. Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor Prognostic Markers in Gastric Adenocarcinoma. J Oncol 2022;2022:9080460. [PMID: 35726219 DOI: 10.1155/2022/9080460] [Reference Citation Analysis]
|
| 9 |
Koopaie M, Ghafourian M, Manifar S, Younespour S, Davoudi M, Kolahdooz S, Shirkhoda M. Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls. BMC Cancer 2022;22:473. [PMID: 35488257 DOI: 10.1186/s12885-022-09570-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Zhang Y, Lin W, Jiang W, Wang Z. MicroRNA-18 facilitates the stemness of gastric cancer by downregulating HMGB3 though targeting Meis2. Bioengineered 2022;13:9959-72. [PMID: 35416122 DOI: 10.1080/21655979.2022.2062529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Kim HJ, Ryu KJ, Kim M, Kim T, Kim SH, Han H, Kim H, Hong KS, Song CY, Choi Y, Hwangbo C, Kim KD, Yoo J. RhoGDI2-Mediated Rac1 Recruitment to Filamin A Enhances Rac1 Activity and Promotes Invasive Abilities of Gastric Cancer Cells. Cancers (Basel) 2022;14:255. [PMID: 35008419 DOI: 10.3390/cancers14010255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Ningthoujam R, Chanu NB, Anumala V, Babu PJ, Pradhan S, Panda MK, Heisnam P, Singh YD. Predicting Biomarkers and Therapeutic Targets in Cancer. Computational Intelligence in Oncology 2022. [DOI: 10.1007/978-981-16-9221-5_13] [Reference Citation Analysis]
|
| 13 |
Kasaeian A, Roshanaei G, Kiumarsi A, Safari M, Abbasi M, Rahimi A. Influential factors on survival in gastric cancer: A single-center study. J Res Med Sci 2022;27:19. [DOI: 10.4103/jrms.jrms_1286_20] [Reference Citation Analysis]
|
| 14 |
Bagchi A. Molecular Analysis of the Involvements of lncRNA in Cancer Development. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects 2022. [DOI: 10.1007/978-981-15-9411-3_153] [Reference Citation Analysis]
|
| 15 |
Kaushik P, Kumar A. Emerging role and function of miR-198 in human health and diseases. Pathol Res Pract 2021;229:153741. [PMID: 34952425 DOI: 10.1016/j.prp.2021.153741] [Reference Citation Analysis]
|
| 16 |
Li Y, Li JQ, Jiang HP, Li X. The Upregulation of PLXDC2 Correlates with Immune Microenvironment Characteristics and Predicts Prognosis in Gastric Cancer. Dis Markers 2021;2021:5669635. [PMID: 34777633 DOI: 10.1155/2021/5669635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Qian S, Villarejo-Campos P, García-Olmo D. The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications. J Clin Med 2021;10:5050. [PMID: 34768570 DOI: 10.3390/jcm10215050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Hu S, Liu H, Zhang J, Li S, Zhou H, Gao Y. Effects and prognostic values of miR-30c-5p target genes in gastric cancer via a comprehensive analysis using bioinformatics. Sci Rep 2021;11:20584. [PMID: 34663825 DOI: 10.1038/s41598-021-00043-w] [Reference Citation Analysis]
|
| 19 |
Almeida GM, Pereira C, Park JH, Lemos C, Campelos S, Gullo I, Martins D, Gonçalves G, Leitão D, Neto JL, André A, Borges C, Almeida D, Lee HJ, Kong SH, Kim WH, Carneiro F, Almeida R, Yang HK, Oliveira C. CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer Patients. Biomedicines 2021;9:1249. [PMID: 34572441 DOI: 10.3390/biomedicines9091249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Hui Y, Yang Y, Li D, Wang J, Di M, Zhang S, Wang S. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2. Cell Transplant 2020;29:963689720925059. [PMID: 32638620 DOI: 10.1177/0963689720925059] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 21 |
Zhang Y, Ding L, Ni Q, Tao R, Qin J. Transcription factor PAX4 facilitates gastric cancer progression through interacting with miR-27b-3p/Grb2 axis. Aging (Albany NY) 2021;13:16786-803. [PMID: 34162761 DOI: 10.18632/aging.203214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Sun Z, Qiu Z, Wang Z, Chi H, Shan P. Silencing Ribosomal Protein L22 Promotes Proliferation and Migration, and Inhibits Apoptosis of Gastric Cancer Cells by Regulating the Murine Double Minute 2-Protein 53 (MDM2-p53) Signaling Pathway. Med Sci Monit 2021;27:e928375. [PMID: 34050122 DOI: 10.12659/MSM.928375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 23 |
Wang BG, Li YZ, Ding HX, Lv Z, Xu Q, Yuan Y. HOTTIP polymorphism may affect gastric cancer susceptibility by altering HOTTIP expression. Biosci Rep 2020;40:BSR20191687. [PMID: 32725141 DOI: 10.1042/BSR20191687] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 24 |
Lourenço BN, Pereira RF, Barrias CC, Fischbach C, Oliveira C, Granja PL. Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells. Nanomaterials (Basel) 2021;11:295. [PMID: 33498669 DOI: 10.3390/nano11020295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Khanipouyani F, Akrami H, Fattahi MR. Circular RNAs as important players in human gastric cancer. Clin Transl Oncol 2021;23:10-21. [DOI: 10.1007/s12094-020-02419-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 26 |
Bagchi A. Molecular Analysis of the Involvements of lncRNA in Cancer Development. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects 2021. [DOI: 10.1007/978-981-15-4501-6_153-1] [Reference Citation Analysis]
|
| 27 |
Liang F, Zhang H, Qiu Y, Xu Q, Jian K, Jiang L, Wang F, Lu X. MiR-124-5p Inhibits the Progression of Gastric Cancer by Targeting MIEN1. Technol Cancer Res Treat 2020;19:1533033820979199. [PMID: 33349155 DOI: 10.1177/1533033820979199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 28 |
Kwon HN, Lee H, Park JW, Kim YH, Park S, Kim JJ. Screening for Early Gastric Cancer Using a Noninvasive Urine Metabolomics Approach. Cancers (Basel) 2020;12:E2904. [PMID: 33050308 DOI: 10.3390/cancers12102904] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 29 |
Hasan S. An Overview of Promising Biomarkers in Cancer Screening and Detection. Curr Cancer Drug Targets 2020;20:831-52. [PMID: 32838718 DOI: 10.2174/1568009620666200824102418] [Reference Citation Analysis]
|
| 30 |
Wang Z, Liu X, Liu X, Niu D. Long Non-Coding RNA BLACAT1 Promotes the Tumorigenesis of Gastric Cancer by Sponging microRNA-149-5p and Targeting KIF2A. Cancer Manag Res 2020;12:6629-40. [PMID: 32801897 DOI: 10.2147/CMAR.S258178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 31 |
Gullo I, Costa C, Silva SL, Ferreira C, Motta A, Silva SP, Ferreira RD, Rosmaninho P, Faria E, Costa JTD, Câmara R, Gonçalves G, Santos-Antunes J, Oliveira C, Machado JC, Carneiro F, Sousa AE. The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric Cancer. Cells 2020;9:E1498. [PMID: 32575504 DOI: 10.3390/cells9061498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 32 |
Virgilio E, Giarnieri E, Giovagnoli MR, Montagnini M, Villani S, Proietti A, D'Urso R, Cardelli P, Balducci G, Cavallini M. Combined Analysis of Intragastric Malignant Exfoliation and Ca 72.4 Concentration in Stomach Adenocarcinoma: The "GL1 Ca 72.4" Parameter. Acta Cytol 2020;64:563-71. [PMID: 32526755 DOI: 10.1159/000508019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 33 |
Wu Y, Li Y, Liu J, Chen M, Li W, Chen Y, Xu M. The diagnostic value of extracellular protein kinase A (ECPKA) in serum for gastric and colorectal cancer. Transl Cancer Res 2020;9:3870-8. [PMID: 35117754 DOI: 10.21037/tcr-20-764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 34 |
Kasurinen A, Laitinen A, Kokkola A, Stenman UH, Böckelman C, Haglund C. Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer. Acta Oncol 2020;59:681-8. [PMID: 32124669 DOI: 10.1080/0284186X.2020.1733655] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Li Z, Liu Z, Shao Z, Li C, Li Y, Liu Q, Zhang Y, Tan B, Liu Y. Identifying multiple collagen gene family members as potential gastric cancer biomarkers using integrated bioinformatics analysis. PeerJ 2020;8:e9123. [PMID: 32509452 DOI: 10.7717/peerj.9123] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 36 |
Kanda M, Suh YS, Park DJ, Tanaka C, Ahn SH, Kong SH, Lee HJ, Kobayashi D, Fujiwara M, Shimada H, Cho B, Murotani K, Kim HH, Yang HK, Kodera Y. Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study. Gastric Cancer 2020;23:203-11. [PMID: 31377880 DOI: 10.1007/s10120-019-00995-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 37 |
Yuan K, Ye J, Liu Z, Ren Y, He W, Xu J, He Y, Yuan Y. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression. J Exp Clin Cancer Res 2020;39:9. [PMID: 31928530 DOI: 10.1186/s13046-019-1514-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 38 |
Li L, Yin X, Meng H, Hu J, Yu Z, Xu J. Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients. Yonsei Med J 2020;61:15-9. [PMID: 31887795 DOI: 10.3349/ymj.2020.61.1.15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 39 |
Sharma PC, Verma R. Current Status of MicroRNA-Based Biomarkers for Gastric Cancer. Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers 2020. [DOI: 10.1007/978-981-15-4431-6_6] [Reference Citation Analysis]
|
| 40 |
Gupta MK, Rajeswari J, Reddy PR, Kumar KS, Chamundeswaramma KV, Vadde R. Genetic Marker Identification for the Detection of Early-Onset Gastric Cancer Through Genome-Wide Association Studies. Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers 2020. [DOI: 10.1007/978-981-15-4431-6_11] [Reference Citation Analysis]
|
| 41 |
Xue J, Li Y, Yi J, Jiang H. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome. Gastroenterol Res Pract 2019;2019:6746970. [PMID: 31885544 DOI: 10.1155/2019/6746970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 42 |
Bie LY, Li D, Wei Y, Li N, Chen XB, Luo SX. SOX13 dependent PAX8 expression promotes the proliferation of gastric carcinoma cells. Artif Cells Nanomed Biotechnol 2019;47:3180-7. [PMID: 31353958 DOI: 10.1080/21691401.2019.1646751] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 43 |
Wang J, Lv B, Su Y, Wang X, Bu J, Yao L. Exosome-Mediated Transfer of lncRNA HOTTIP Promotes Cisplatin Resistance in Gastric Cancer Cells by Regulating HMGA1/miR-218 Axis. Onco Targets Ther 2019;12:11325-38. [PMID: 31908497 DOI: 10.2147/OTT.S231846] [Cited by in Crossref: 49] [Cited by in F6Publishing: 61] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 44 |
Li X, Na H, Xu L, Zhang X, Feng Z, Zhou X, Cui J, Zhang J, Lin F, Yang S, Yue F, Mousa H, Zuo Y. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression. Biomed Pharmacother 2020;121:109644. [PMID: 31766099 DOI: 10.1016/j.biopha.2019.109644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 45 |
Zheng R, Liang J, Lu J, Li S, Zhang G, Wang X, Liu M, Wang W, Chu H, Tao G, Zhao Q, Wang M, Du M, Qiang F, Zhang Z. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis. Gastric Cancer 2019;22:731-41. [PMID: 30603909 DOI: 10.1007/s10120-018-00915-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 46 |
Li D, Li C. The diagnostic performance of serum LIM homeobox transcription factor 1 alpha in patients with gastric cancer. Medicine (Baltimore) 2019;98:e15783. [PMID: 31145300 DOI: 10.1097/MD.0000000000015783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 47 |
Lv J, Zhao R, Wu D, Zheng D, Wu Z, Shi J, Wei X, Wu Q, Long Y, Lin S, Wang S, Wang Z, Li Y, Chen Y, He Q, Chen S, Yao H, Liu Z, Tang Z, Yao Y, Pei D, Liu P, Zhang X, Zhang Z, Cui S, Chen R, Li P. Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer. J Hematol Oncol 2019;12:18. [PMID: 30777106 DOI: 10.1186/s13045-019-0704-y] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 48 |
Uno Y, Kanda M, Miwa T, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer. Ann Surg Oncol 2019;26:836-44. [PMID: 30617870 DOI: 10.1245/s10434-018-07149-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 49 |
贺 礼. Research Progress on Anti-Tumor Effect of Metformin in Gastric Cancer. ACM 2019;09:831-836. [DOI: 10.12677/acm.2019.97128] [Reference Citation Analysis]
|
| 50 |
Gullo I, Oliveira P, Athelogou M, Gonçalves G, Pinto ML, Carvalho J, Valente A, Pinheiro H, Andrade S, Almeida GM, Huss R, Das K, Tan P, Machado JC, Oliveira C, Carneiro F. New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression. Gastric Cancer 2019;22:77-90. [PMID: 29779068 DOI: 10.1007/s10120-018-0836-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 51 |
Kasurinen A, Tervahartiala T, Laitinen A, Kokkola A, Sorsa T, Böckelman C, Haglund C. High serum MMP-14 predicts worse survival in gastric cancer. PLoS One 2018;13:e0208800. [PMID: 30532247 DOI: 10.1371/journal.pone.0208800] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 52 |
Pereira C, Ferreira D, Lemos C, Martins D, Mendes N, Almeida D, Granja P, Carneiro F, Almeida R, Almeida GM, Oliveira C. CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients.. [DOI: 10.1101/468934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 53 |
Su C, Li H, Peng Z, Ke D, Fu H, Zheng X. Identification of plasma RGS18 and PPBP mRNAs as potential biomarkers for gastric cancer using transcriptome arrays. Oncol Lett 2019;17:247-55. [PMID: 30655761 DOI: 10.3892/ol.2018.9608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 54 |
Yang Z, Jiang X, Li D, Dong Q, Zhao H, Jiang X. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer. Gene 2019;682:42-9. [PMID: 30296564 DOI: 10.1016/j.gene.2018.10.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 55 |
Chang P, Wang F, Li Y. Hsa_circ_0000673 is down-regulated in gastric cancer and inhibits the proliferation and invasion of tumor cells by targetting miR-532-5p. Biosci Rep 2018;38:BSR20180538. [PMID: 30061181 DOI: 10.1042/BSR20180538] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 56 |
Ding Z, Lan H, Xu R, Zhou X, Pan Y. LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis. Pathol Res Pract. 2018;214:1993-1999. [PMID: 30279010 DOI: 10.1016/j.prp.2018.09.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 57 |
Liu HT, Liu S, Liu L, Ma RR, Gao P. EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer. Cancer Res 2018;78:5877-90. [PMID: 30185552 DOI: 10.1158/0008-5472.CAN-18-1011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 90] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 58 |
Kanda M, Tanaka C, Kobayashi D, Uda H, Inaoka K, Tanaka Y, Hayashi M, Iwata N, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. Preoperative Albumin-Bilirubin Grade Predicts Recurrences After Radical Gastrectomy in Patients with pT2-4 Gastric Cancer. World J Surg 2018;42:773-81. [PMID: 28920160 DOI: 10.1007/s00268-017-4234-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 59 |
Virgilio E, Giarnieri E, Giovagnoli MR, Montagnini M, Proietti A, D'Urso R, Mercantini P, Balducci G, Cavallini M. Long non-coding RNAs in the gastric juice of gastric cancer patients. Pathol Res Pract 2018;214:1239-46. [PMID: 30078471 DOI: 10.1016/j.prp.2018.07.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 60 |
Tajirika T, Tokumaru Y, Taniguchi K, Sugito N, Matsuhashi N, Futamura M, Yanagihara K, Akao Y, Yoshida K. DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer Cells. Int J Mol Sci 2018;19:E2005. [PMID: 29987267 DOI: 10.3390/ijms19072005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 61 |
Abbas M, Faggian A, Sintali DN, Khan GJ, Naeem S, Shi M, Dingding C. Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy 2018;103:1688-700. [DOI: 10.1016/j.biopha.2018.04.178] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 62 |
Thapa S, Chetry M, Huang K, Peng Y, Wang J, Wang J, Zhou Y, Shen Y, Xue Y, Ji K. Significance of aquaporins' expression in the prognosis of gastric cancer. Biosci Rep 2018;38:BSR20171687. [PMID: 29678898 DOI: 10.1042/BSR20171687] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 63 |
Li D, Chen Y, Mei H, Jiao W, Song H, Ye L, Fang E, Wang X, Yang F, Huang K, Zheng L, Tong Q. Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression. Oncogene 2018;37:4871-86. [PMID: 29773901 DOI: 10.1038/s41388-018-0302-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 64 |
Jiang X, Jiang X, Yang Z. NRAGE confers poor prognosis and promotes proliferation, invasion, and chemoresistance in gastric cancer. Gene 2018;668:114-20. [PMID: 29778424 DOI: 10.1016/j.gene.2018.05.060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 65 |
Lu C, Cai D, Ma J. Pachymic Acid Sensitizes Gastric Cancer Cells to Radiation Therapy by Upregulating Bax through Hypoxia.Am J Chin Med. 2018;46:875-890. [PMID: 29737213 DOI: 10.1142/S0192415X18500465] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 66 |
Kanda M, Murotani K, Tanaka H, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Hattori N, Suenaga M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer. Cancer Med 2018;7:2463-71. [PMID: 29733517 DOI: 10.1002/cam4.1522] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 67 |
Sawaki K, Kanda M, Miwa T, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer. Ann Surg Oncol 2018;25:2083-90. [PMID: 29663169 DOI: 10.1245/s10434-018-6480-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 68 |
Luo C, Tao Y, Zhang Y, Zhu Y, Minyao DN, Haleem M, Dong C, Zhang L, Zhang X, Zhao J, Liao Q. Regulatory network analysis of high expressed long non-coding RNA LINC00941 in gastric cancer. Gene 2018;662:103-9. [PMID: 29653230 DOI: 10.1016/j.gene.2018.04.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 69 |
Kanda M, Murotani K, Tanaka H, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Hattori N, Suenaga M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. Integrated multigene expression panel to prognosticate patients with gastric cancer. Oncotarget 2018;9:18775-85. [PMID: 29721160 DOI: 10.18632/oncotarget.24661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Li W, Jia H, Wang J, Guan H, Li Y, Zhang D, Tang Y, Wang TD, Lu S. A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer. Oncotarget 2017;8:30063-76. [PMID: 28415792 DOI: 10.18632/oncotarget.16275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 71 |
Motoshima S, Yonemoto K, Kamei H, Morita M, Yamaguchi R. Prognostic implications of HER2 heterogeneity in gastric cancer. Oncotarget. 2018;9:9262-9272. [PMID: 29507688 DOI: 10.18632/oncotarget.24265] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 72 |
Zheng L, Jiao W, Mei H, Song H, Li D, Xiang X, Chen Y, Yang F, Li H, Huang K, Tong Q. miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14. Oncotarget 2016;7:40314-28. [PMID: 27259238 DOI: 10.18632/oncotarget.9739] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 73 |
Feng C, Xian Q, Liu S. Micro RNA-518 inhibits gastric cancer cell growth by inducing apoptosis via targeting MDM2. Biomedicine & Pharmacotherapy 2018;97:1595-602. [DOI: 10.1016/j.biopha.2017.11.091] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 74 |
Li X, Li Z, Liu Z, Xiao J, Yu S, Song Y. Long non-coding RNA DLEU1 predicts poor prognosis of gastric cancer and contributes to cell proliferation by epigenetically suppressing KLF2. Cancer Gene Ther 2018;25:58-67. [DOI: 10.1038/s41417-017-0007-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 75 |
Li P, Zhang C, Gao P, Chen X, Ma B, Yu D, Song Y, Wang Z. Metformin use and its effect on gastric cancer in patients with type 2 diabetes: A systematic review of observational studies. Oncol Lett 2018;15:1191-9. [PMID: 29391902 DOI: 10.3892/ol.2017.7370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 76 |
Lu C, Ma J, Cai D. Pachymic acid inhibits the tumorigenicity of gastric cancer cells by the mitochondrial pathway. Anticancer Drugs 2017;28:170-9. [PMID: 27792037 DOI: 10.1097/CAD.0000000000000449] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 77 |
Chen H, Li H, Zhao J, Peng P, Shao M, Wu H, Wang X, Chen L, Zhang Q, Ruan Y, Liu F, Sun Y. High Intratumoral Expression of Tetranectin Associates with Poor Prognosis of Patients with Gastric Cancer after Gastrectomy. J Cancer 2017;8:3623-30. [PMID: 29151948 DOI: 10.7150/jca.19438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 78 |
Carlomagno N, Incollingo P, Tammaro V, Peluso G, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E, Sabbatini M, Bracale UM, Calogero A, Dodaro CA, Santangelo M. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. Biomed Res Int. 2017;2017:7869802. [PMID: 29094049 DOI: 10.1155/2017/7869802] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 79 |
Kwon MJ, Kim RN, Song K, Jeon S, Jeong HM, Kim JS, Han J, Hong S, Oh E, Choi JS, An J, Pollack JR, Choi YL, Park CK, Shin YK. Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer. Oncotarget 2017;8:92209-26. [PMID: 29190909 DOI: 10.18632/oncotarget.21150] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 80 |
Zheng L, Chen Y, Ye L, Jiao W, Song H, Mei H, Li D, Yang F, Li H, Huang K, Tong Q. miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1- facilitated MMP-14 expression. Sci Rep 2017;7:8967. [PMID: 28827574 DOI: 10.1038/s41598-017-09271-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 81 |
Wang S, Han H, Hu Y, Yang W, Lv Y, Wang L, Zhang L, Ji J. SLC3A2, antigen of mAb 3G9, promotes migration and invasion by upregulating of mucins in gastric cancer. Oncotarget 2017;8:88586-98. [PMID: 29179459 DOI: 10.18632/oncotarget.19529] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 82 |
Korsak B, Almeida GM, Rocha S, Pereira C, Mendes N, Osório H, Pereira PM, Rodrigues JM, Schneider RJ, Sarmento B, Tomé JP, Oliveira C. Porphyrin modified trastuzumab improves efficacy of HER2 targeted photodynamic therapy of gastric cancer. Int J Cancer 2017;141:1478-89. [DOI: 10.1002/ijc.30844] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 83 |
Wang X, Zhou Q, Yu Z, Wu X, Chen X, Li J, Li C, Yan M, Zhu Z, Liu B, Su L. Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin β1-FAK signaling pathway: Tumor-promoting effects of stromal Lumican in gastric cancer. Int J Cancer 2017;141:998-1010. [DOI: 10.1002/ijc.30801] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 84 |
Shao Y, Chen L, Lu R, Zhang X, Xiao B, Ye G, Guo J. Decreased expression of hsa_circ_0001895 in human gastric cancer and its clinical significances. Tumour Biol. 2017;39:1010428317699125. [PMID: 28443463 DOI: 10.1177/1010428317699125] [Cited by in Crossref: 57] [Cited by in F6Publishing: 71] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 85 |
Karbyshev MS, Grigoryeva ES, Volkomorov VV, Kremmer E, Huber A, Mitrofanova IV, Kaigorodova EV, Zavyalova MV, Kzhyshkowska JG, Cherdyntseva NV, Choynzonov EL. Development of Novel Monoclonal Antibodies for Evaluation of Transmembrane Prostate Androgen-Induced Protein 1 (TMEPAI) Expression Patterns in Gastric Cancer. Pathol Oncol Res 2018;24:427-38. [DOI: 10.1007/s12253-017-0247-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 86 |
Han J, Meng Q, Xi Q, Wang H, Wu G. PFKFB3 was overexpressed in gastric cancer patients and promoted the proliferation and migration of gastric cancer cells. Cancer Biomark 2017;18:249-56. [PMID: 27983531 DOI: 10.3233/CBM-160143] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 87 |
Panarese I, De Vita F, Ronchi A, Romano M, Alfano R, Di Martino N, Zito Marino F, Ferraraccio F, Franco R. Predictive biomarkers along gastric cancer pathogenetic pathways. Expert Rev Anticancer Ther 2017;17:417-25. [PMID: 28277834 DOI: 10.1080/14737140.2017.1301207] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 88 |
Qu B, Yao L, Ma HL, Chen HL, Zhang Z, Xie J. Prognostic significance of autophagy-related proteins expression in resected human gastric adenocarcinoma. J Huazhong Univ Sci Technolog Med Sci 2017;37:37-43. [PMID: 28224423 DOI: 10.1007/s11596-017-1691-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 89 |
Chen J, Ying X, Zhang L, Xiang X, Xiong J. Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients. Wien Klin Wochenschr 2017;129:420-6. [DOI: 10.1007/s00508-016-1147-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 90 |
Pinjari AB, Meerza AR. Role of STAT3 in Gastric Cancer Initiation, Development, and Progression. Role of Transcription Factors in Gastrointestinal Malignancies 2017. [DOI: 10.1007/978-981-10-6728-0_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 91 |
Jella KK. Activation of STAT3 in Gastric Cancer Development. Role of Transcription Factors in Gastrointestinal Malignancies 2017. [DOI: 10.1007/978-981-10-6728-0_11] [Reference Citation Analysis]
|
| 92 |
Sukharamwala P, Hennessey D, Wood T, Singh S, Ryan C, Rosemurgy A. Molecular profiles in foregut oncology. Cancer Genet 2016;209:537-53. [PMID: 27887938 DOI: 10.1016/j.cancergen.2016.09.008] [Reference Citation Analysis]
|
| 93 |
Zhang Y, Chen Z, Li MJ, Guo HY, Jing NC. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression. Biomed Pharmacother. 2017;85:264-271. [PMID: 27887846 DOI: 10.1016/j.biopha.2016.11.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 94 |
Van Laethem JL, Carneiro F, Ducreux M, Messman H, Lordick F, Ilson DH, Allum WH, Haustermans K, Lepage C, Matysiak-Budnik T, Cats A, Schmiegel W, Cervantes A, Van Cutsem E, Rougier P, Seufferlein T. The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona. Dig Liver Dis 2016;48:1283-9. [PMID: 27590840 DOI: 10.1016/j.dld.2016.08.112] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 95 |
Zheng L, Jiao W, Song H, Qu H, Li D, Mei H, Chen Y, Yang F, Li H, Huang K, Tong Q. miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression. Cell Death Dis 2016;7:e2382. [PMID: 27685626 DOI: 10.1038/cddis.2016.293] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 96 |
Kanda M, Kodera Y, Sakamoto J. Updated evidence on adjuvant treatments for gastric cancer. Expert Rev Gastroenterol Hepatol 2015;9:1549-60. [PMID: 26414453 DOI: 10.1586/17474124.2015.1094373] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 97 |
Kanda M, Kodera Y. Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol 2016; 22(30): 6829-6840 [PMID: 27570420 DOI: 10.3748/wjg.v22.i30.6829] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 95] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 98 |
Baniak N, Senger JL, Ahmed S, Kanthan SC, Kanthan R. Gastric biomarkers: a global review. World J Surg Oncol. 2016;14:212. [PMID: 27514667 DOI: 10.1186/s12957-016-0969-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 99 |
Tsuburaya A, Sugimoto N, Imamura H, Nishikawa K, Imamoto H, Tsujinaka T, Esaki T, Horita Y, Kimura Y, Fujiya T, Takayama O, Oono R, Yabusaki H, Taguri M, Morita S, Yamada Y, Tan P, Ninomiya M, Furukawa H, Sasako M. Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002). Clinical Oncology 2016;28:e45-51. [DOI: 10.1016/j.clon.2016.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 100 |
Guo G, He Z, Shi Z. Correlation between FOXP3 expression and gastric cancer. Oncol Lett 2016;12:1554-8. [PMID: 27446470 DOI: 10.3892/ol.2016.4752] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 101 |
Kanda M, Shimizu D, Fujii T, Tanaka H, Tanaka Y, Ezaka K, Shibata M, Takami H, Hashimoto R, Sueoka S. Neurotrophin Receptor-interacting Melanoma Antigen-encoding Gene Homolog Is Associated with Malignant Phenotype of Gastric Cancer. Ann Surg Oncol. 2016; Epub ahead of print. [PMID: 27364510 DOI: 10.1245/s10434-016-5375-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 102 |
Liang B, Zheng W, Fang L, Wu L, Zhou F, Yin X, Yu X, Zou Z. Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer. Cancer Biol Ther. 2016;17:824-832. [PMID: 27314162 DOI: 10.1080/15384047.2016.1195046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 103 |
Ye H, Liu K, Qian K. Overexpression of long noncoding RNA HOTTIP promotes tumor invasion and predicts poor prognosis in gastric cancer. Onco Targets Ther 2016;9:2081-8. [PMID: 27103834 DOI: 10.2147/OTT.S95414] [Cited by in Crossref: 15] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 104 |
Cui Z, Zheng X, Kong D. Decreased miR-198 expression and its prognostic significance in human gastric cancer. World J Surg Oncol. 2016;14:33. [PMID: 26852230 DOI: 10.1186/s12957-016-0784-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 105 |
Ji K, Zhang L, Zhang M, Chu Q, Li X, Wang W. Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2016;95:e2641. [PMID: 26844481 DOI: 10.1097/MD.0000000000002641] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 106 |
Ma B, Wang J, Song Y, Gao P, Sun J, Chen X, Yang Y, Wang Z. Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer. Onco Targets Ther 2016;9:445-53. [PMID: 26855593 DOI: 10.2147/OTT.S98613] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 107 |
Kanda M, Kodera Y. Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol 2015; 21(34): 9838-9852 [PMID: 26379391 DOI: 10.3748/wjg.v21.i34.9838] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 84] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 108 |
Kanda M, Shimizu D, Fujii T, Sueoka S, Tanaka Y, Ezaka K, Takami H, Tanaka H, Hashimoto R, Iwata N. Function and diagnostic value of Anosmin-1 in gastric cancer progression. Int J Cancer. 2016;138:721-730. [PMID: 26270236 DOI: 10.1002/ijc.29803] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 109 |
ElHalawani H, Abdel-Rahman O. Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers. Ther Clin Risk Manag. 2015;11:1123-1132. [PMID: 26251608 DOI: 10.2147/tcrm.s71045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 110 |
Wang JF, Xie Y, Hu L, Li CR, Li HL. Detection of gastric juice microRNAs for screening and diagnosis of gastric cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(16): 2562-2567 [DOI: 10.11569/wcjd.v23.i16.2562] [Reference Citation Analysis]
|
| 111 |
Zhang W, Liang P, Wang W, Dai P, Wang Q, Yan W, Zhao J, Sun J, Peng Y, Cui D, Yan Z. The Influence of PSCA Gene Variation on Its Expression and Gastric Adenocarcinoma Susceptibility in the Northwest Chinese Population. Int J Mol Sci 2015;16:11648-58. [PMID: 26006239 DOI: 10.3390/ijms160511648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 112 |
Thiel A, Ristimäki A. Targeted therapy in gastric cancer. APMIS. 2015;123:365-372. [PMID: 25706252 DOI: 10.1111/apm.12359] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 113 |
Carcas LP. Gastric cancer review. J Carcinog. 2014;13:14. [PMID: 25589897 DOI: 10.4103/1477-3163.146506] [Cited by in Crossref: 136] [Cited by in F6Publishing: 157] [Article Influence: 15.1] [Reference Citation Analysis]
|
| 114 |
Velho S, Fernandes MS, Leite M, Figueiredo C, Seruca R. Causes and consequences of microsatellite instability in gastric carcinogenesis. World J Gastroenterol 2014; 20(44): 16433-16442 [PMID: 25469011 DOI: 10.3748/wjg.v20.i44.16433] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 115 |
Yoon JH, Choi WS, Kim O, Park WS. The role of gastrokine 1 in gastric cancer. J Gastric Cancer. 2014;14:147-155. [PMID: 25328759 DOI: 10.5230/jgc.2014.14.3.147] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 116 |
Chen X, Sun J, Song Y, Gao P, Zhao J, Huang X, Liu B, Xu H, Wang Z. The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancer. Med Oncol. 2014;31:262. [PMID: 25260808 DOI: 10.1007/s12032-014-0262-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 117 |
Cao HY, Yuan AH, Chen W, Shi XS, Miao Y. A DNA aptamer with high affinity and specificity for molecular recognition and targeting therapy of gastric cancer. BMC Cancer 2014;14:699. [PMID: 25248985 DOI: 10.1186/1471-2407-14-699] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 118 |
Luo Y, Li Z, Cui S, Shen C, Zhao J, Wu M, Li Y, Wang M, Chen R, Liu Z. Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients. Eur J Med Res. 2014;19:50. [PMID: 25223338 DOI: 10.1186/s40001-014-0050-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 119 |
Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu Z, Ye G, Zhang X, Xiao B, Guo J. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer. 2014;120:3320-3328. [PMID: 24986041 DOI: 10.1002/cncr.28882] [Cited by in Crossref: 126] [Cited by in F6Publishing: 137] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 120 |
Liu Z, Shao Y, Tan L, Shi H, Chen S, Guo J. Clinical significance of the low expression of FER1L4 in gastric cancer patients. Tumour Biol. 2014;35:9613-9617. [PMID: 24961353 DOI: 10.1007/s13277-014-2259-4] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 121 |
Shao Y, Chen H, Jiang X, Chen S, Li P, Ye M, Li Q, Sun W, Guo J. Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol. 2014;35:9591-9595. [PMID: 24961350 DOI: 10.1007/s13277-014-2243-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 52] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 122 |
Bosman FT, True LD. Prognostic biomarkers: an introduction. Virchows Arch 2014;464:253-6. [PMID: 24562304 DOI: 10.1007/s00428-014-1553-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
